Structural reassignment of a dibenz[b,f][1,4]oxazepin-11(10H)-one with potent antigiardial activity

被引:2
作者
Riches, Andrew G. [1 ]
Hart, Christopher J. S. [2 ,3 ]
Schmit, Matthieu [1 ]
Debele, Emmanuel A. [1 ]
Tiash, Snigdha [2 ]
Clapper, Erin [2 ]
Skinner-Adams, Tina S. [2 ]
Ryan, John H. [1 ]
机构
[1] CSIRO Mfg, Ian Wark Lab, Bayview Ave, Clayton, Vic 3168, Australia
[2] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld 4111, Australia
[3] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA
基金
英国医学研究理事会;
关键词
antigiardial; dibenzoxazepinones; Giardia; giardiasis; medicinal chemistry; organic synthesis; parasite; screening; structural reassignment;
D O I
10.1071/CH22184
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A screen for compounds with antigiardial activity in the Compounds Australia Scaffolds library identified SN00797640 (supplied structure being 8-acylaminodibenzoxazepinone 1) as a hit compound with potent anti-parasitic activity (concentration for 50% growth inhibition of Giardia duodenalis, IC50 0.18 mu M). To further explore the structure-activity relationships in this series, compound 1 and analogues, including its 7-acylaminodibenzoxazepinone regioisomer (2), were synthesized and assessed for anti-Giardia activity. While regioisomer 2 demonstrated antigiardial activity, resynthesized 1 and other 8-acylaminodibenzoxazepinone analogues were inactive. Comparison of spectroscopic and physical properties demonstrated the correct structure of SN00797640 to be 7-acylamino regioisomer 2. These results highlight the importance of independent synthesis in verifying the structure and activity of screening hits.
引用
收藏
页码:839 / 845
页数:7
相关论文
共 15 条
  • [1] Observations on screening-based research and some concerning trends in the literature
    Baell, Jonathan B.
    [J]. FUTURE MEDICINAL CHEMISTRY, 2010, 2 (10) : 1529 - 1546
  • [2] Dahlin JL, 2014, FUTURE MED CHEM, V6, P1265, DOI [10.4155/FMC.14.60, 10.4155/fmc.14.60]
  • [3] Go YJ, 2018, Korean Patent, Patent No. [WO2018/174442A1, 2018174442]
  • [4] A novel in vitro image-based assay identifies new drug leads for giardiasis
    Hart, Christopher J. S.
    Munro, Taylah
    Andrews, Katherine T.
    Ryan, John H.
    Riches, Andrew G.
    Skinner-Adams, Tina S.
    [J]. INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2017, 7 (01): : 83 - 89
  • [5] A COMPARISON OF 3 METHODS OF ESTIMATING EC(50) IN STUDIES OF DRUG-RESISTANCE OF MALARIA PARASITES
    HUBER, W
    KOELLA, JC
    [J]. ACTA TROPICA, 1993, 55 (04) : 257 - 261
  • [6] Ibrom WGA, 1997, ARZNEIMITTEL-FORSCH, V47, P662
  • [8] NOVEL NONNUCLEOSIDE INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE .2. TRICYCLIC PYRIDOBENZOXAZEPINONES AND DIBENZOXAZEPINONES
    KLUNDER, JM
    HARGRAVE, KD
    WEST, MA
    CULLEN, E
    PAL, K
    BEHNKE, ML
    KAPADIA, SR
    MCNEIL, DW
    WU, JC
    CHOW, GC
    ADAMS, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (10) : 1887 - 1897
  • [9] Regioselective Synthesis of Fused Oxazepinone Scaffolds through One-Pot Smiles Rearrangement Tandem Reaction
    Liu, Yanli
    Chu, Chunxiao
    Huang, Aiping
    Zhan, Chunjing
    Ma, Ying
    Ma, Chen
    [J]. ACS COMBINATORIAL SCIENCE, 2011, 13 (05) : 547 - 553
  • [10] NAGARAJA.K, 1974, INDIAN J CHEM, V12, P236